Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPARα and INSIG/SREBP1c pathway
Yiqing Gu(Beijing University of Chinese Medicine), Runping Liu(Beijing University of Chinese Medicine), Mingning Ding(Beijing University of Chinese Medicine), Xiaojiaoyang Li(Beijing University of Chinese Medicine), Chuanyang Liu(National University of Defense Technology), Shuni Duan(Beijing University of Chinese Medicine), Yijie Li(Beijing University of Chinese Medicine), Rong Sun(Jinan University), Qi Zheng(Fujian Medical University), Guifang Fan(Beijing University of Chinese Medicine)
Cited by 47
Related Papers
Alkaline pretreatment for enhancement of biogas production from banana stem and swine manure by anaerobic codigestion
|Bioresource Technology|2013|89
Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening
|Medical Oncology|2014|69
Ferulic Acid Ameliorates Hepatic Inflammation and Fibrotic Liver Injury by Inhibiting PTP1B Activity and Subsequent Promoting AMPK Phosphorylation
|Frontiers in Pharmacology|2021|65
Tetramethylpyrazine prevents liver fibrotic injury in mice by targeting hepatocyte-derived and mitochondrial DNA-enriched extracellular vesicles
|Acta Pharmacologica Sinica|2022|52
Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways
|Frontiers in Pharmacology|2022|43